ArticleInvestigational new drugs2014

Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: phase i study in Japanese patients with advanced solid malignancies and advanced breast cancer.

Takayasu Kurata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.